Display options
Cite
Castro JG, Morrison-Bryant M. Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions. HIV AIDS (Auckl). 2010;2:123-34doi: 10.2147/hiv.s7720.
Castro, J. G., & Morrison-Bryant, M. (2010). Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions. HIV/AIDS (Auckland, N.Z.), 2123-34. https://doi.org/10.2147/hiv.s7720
Castro, Jose G, and Morrison-Bryant, Maya. "Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions." HIV/AIDS (Auckland, N.Z.) vol. 2 (2010): 123-34. doi: https://doi.org/10.2147/hiv.s7720
Castro JG, Morrison-Bryant M. Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions. HIV AIDS (Auckl). 2010;2:123-34. doi: 10.2147/hiv.s7720. Epub 2010 Feb 18. PMID: 22096390; PMCID: PMC3218692.
Copy Download .nbib Format: NLM
Share it on

HIV AIDS (Auckl). 2010;2:123-34. doi: 10.2147/hiv.s7720. Epub 2010 Feb 18.

Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions.

HIV/AIDS (Auckland, N.Z.)

Jose G Castro, Maya Morrison-Bryant

Affiliations

  1. Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.

PMID: 22096390 PMCID: PMC3218692 DOI: 10.2147/hiv.s7720

Abstract

The discovery of the Human Immunodeficiency Virus (HIV) was led by the merge of clustered cases of Pneumocystis jirovecii Pneumonia (PCP) in otherwise healthy people in the early 80's.1,2 In the face of sophisticated treatment now available for HIV infection, life expectancy approaches normal limits. It has dramatically changed the natural course of HIV from a nearly fatal infection to a chronic disease.3-5 However, PCP still remains a relatively common presentation of uncontrolled HIV. Despite the knowledge and advances gained in the prevention and management of PCP infection, it continues to have high morbidity and mortality rates. Trimethoprim-sulfamethoxazole (TMP-SMZ) remains as the recommended first-line treatment. Alternatives include pentamidine, dapsone plus trimethoprim, clindamycin administered with primaquine, and atovaquone. For optimal management, clinicians need to be familiar with the advantages and disadvantages of the available drugs. The parameters used to classify severity of infection are also important, as it is well known that the adjunctive use of steroids in moderate to severe cases have been shown to significantly improve outcome. Evolving management practices, such as the successful institution of early antiretroviral therapy, may further enhance overall survival rates.

Keywords: HIV; PCP; Pneumocystis Jirovecii; TMP-SMZ

References

  1. Antimicrob Agents Chemother. 1998 Aug;42(8):1985-9 - PubMed
  2. Mayo Clin Proc. 1996 Jan;71(1):5-13 - PubMed
  3. Ann Intern Med. 1994 Aug 1;121(3):174-80 - PubMed
  4. Am J Respir Crit Care Med. 2002 Aug 1;166(3):262-7 - PubMed
  5. AIDS. 2005 May 20;19(8):801-5 - PubMed
  6. N Engl J Med. 1998 Dec 24;339(26):1889-95 - PubMed
  7. Clin Chest Med. 1988 Sep;9(3):473-9 - PubMed
  8. J Infect Dis. 1999 Aug;180(2):369-76 - PubMed
  9. Ann Intern Med. 1980 Jun;92(6):762-9 - PubMed
  10. Lancet. 2001 Aug 18;358(9281):545-9 - PubMed
  11. Emerg Infect Dis. 2002 Sep;8(9):891-6 - PubMed
  12. J Clin Microbiol. 2009 Dec;47(12):3871-4 - PubMed
  13. Ann Intern Med. 1996 May 1;124(9):792-802 - PubMed
  14. Ann Intern Med. 1986 Jul;105(1):37-44 - PubMed
  15. BMC Infect Dis. 2009 Apr 22;9:47 - PubMed
  16. J Infect Dis. 2004 May 1;189(9):1679-83 - PubMed
  17. Scand J Infect Dis. 2007;39(11-12):1054-8 - PubMed
  18. N Engl J Med. 1998 Mar 26;338(13):853-60 - PubMed
  19. AJR Am J Roentgenol. 1997 Oct;169(4):967-75 - PubMed
  20. J Infect Dis. 1985 Jan;151(1):181-6 - PubMed
  21. Am J Respir Crit Care Med. 2001 Sep 1;164(5):847-51 - PubMed
  22. Eur Respir J. 2002 Oct;20(4):982-9 - PubMed
  23. Lancet. 1999 Oct 16;354(9187):1347-51 - PubMed
  24. AIDS. 1992 Mar;6(3):301-5 - PubMed
  25. N Engl J Med. 1981 Dec 10;305(24):1425-31 - PubMed
  26. Microbes Infect. 2000 Jan;2(1):61-7 - PubMed
  27. J Clin Invest. 1992 Aug;90(2):673-8 - PubMed
  28. Chin Med J (Engl). 2009 Apr 20;122(8):996-9 - PubMed
  29. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4 - PubMed
  30. PLoS One. 2009;4(5):e5575 - PubMed
  31. N Engl J Med. 1993 May 27;328(21):1521-7 - PubMed
  32. Transplantation. 2007 Sep 27;84(6):685-8 - PubMed
  33. Ann Intern Med. 1988 Jul 1;109(1):7-10 - PubMed
  34. AIDS. 2003 Jan 3;17(1):73-80 - PubMed
  35. Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):52-4 - PubMed
  36. Emerg Infect Dis. 2003 Jul;9(7):864-7 - PubMed
  37. Infect Immun. 2003 Jul;71(7):3852-6 - PubMed
  38. N Engl J Med. 2006 Jul 13;355(2):173-81 - PubMed
  39. J Acquir Immune Defic Syndr (1988). 1993 May;6(5):472-7 - PubMed
  40. Ann Intern Med. 1990 Jul 1;113(1):14-20 - PubMed
  41. N Engl J Med. 1990 Nov 22;323(21):1500-4 - PubMed
  42. Swiss Med Wkly. 2009 Oct 3;139(39-40):564-70 - PubMed
  43. Clin Infect Dis. 1998 Jul;27(1):191-204 - PubMed
  44. Int J STD AIDS. 1996 Oct;7(6):445-7 - PubMed
  45. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):393-8 - PubMed
  46. Rev Infect Dis. 1982 Mar-Apr;4(2):602-7 - PubMed
  47. N Engl J Med. 1992 Dec 24;327(26):1842-8 - PubMed
  48. Expert Rev Mol Med. 2005 Nov 14;7(26):1-16 - PubMed
  49. J Pediatr. 1978 Feb;92(2):285-91 - PubMed
  50. AIDS. 2007 Aug 20;21(13):1711-5 - PubMed
  51. JAMA. 1995 Mar 15;273(11):848 - PubMed
  52. Clin Infect Dis. 1998 Sep;27(3):524-30 - PubMed
  53. Ann Pharmacother. 1998 May;32(5):549-53 - PubMed
  54. Lancet. 2008 Jul 26;372(9635):293-9 - PubMed
  55. Rev Infect Dis. 1982 Mar-Apr;4(2):608-13 - PubMed
  56. Infect Immun. 1999 Jul;67(7):3452-60 - PubMed
  57. Thorax. 2006 Aug;61(8):716-21 - PubMed
  58. J Protozool. 1989 Jan-Feb;36(1):14S-16S - PubMed
  59. N Engl J Med. 1992 Dec 24;327(26):1836-41 - PubMed
  60. J Emerg Med. 1994 May-Jun;12(3):347-51 - PubMed
  61. J Acquir Immune Defic Syndr (1988). 1992;5(7):726-31 - PubMed
  62. MMWR Morb Mortal Wkly Rep. 1981 Jun 5;30(21):250-2 - PubMed
  63. Nature. 1988 Aug 11;334(6182):519-22 - PubMed
  64. AIDS. 2001 Mar 9;15(4):451-9 - PubMed
  65. Infect Immun. 1993 Dec;61(12):5406-9 - PubMed
  66. N Engl J Med. 1988 Mar 10;318(10):589-93 - PubMed
  67. N Engl J Med. 2004 Jun 10;350(24):2487-98 - PubMed
  68. Ann Intern Med. 1970 Nov;73(5):695-702 - PubMed
  69. Ann Intern Med. 1988 Aug 15;109(4):280-7 - PubMed
  70. J Parasitol. 1988 Aug;74(4):700-12 - PubMed

Publication Types